Cadonilimab Combined with Chemotherapy with or without Bevacizumab as First-Line Treatment in Recurrent or Metastatic Cervical Cancer (COMPASSION-13): A Phase 2 Study.

Published in: Clinical cancer research : an official journal of the American Association for Cancer Research (2024)

Cadonilimab combined with standard therapy was acceptable, with encouraging antitumor activity in patients with R/M CC.

Keyphrases